Cefotaxime

C. diff Risk

High

Oral Bioavailability

NA

Approximate Cost

$30/day

Spectrum Of Activity

Dosing

1-2g IV q4-12h

General Information

Common Usage

Empiric therapy for bacterial meningitis, pneumonia (in combination with a macrolide), intra-abdominal infection including SBP, musculoskeletal i.e. septic arthritis, and urinary tract infection.

Adverse Effects

Rash, localized phlebitis at injection site, allergy.

Positive Coombs test, neutropenia, abnormalities in liver enzymes.

Diarrhea and CDI.

Additional Information

Prefer ceftriaxone for CNS infection in renal failure.

Cefotaxime may be automatically substituted by AHS pharmacy to ceftriaxone due to cost and ease of dosing.

If you order it specifically, specify no substitution otherwise preference is for ceftriaxone

Pharmacology

Antimicrobial class: 3rd Generation Cephalosporin

Pregnancy category: B

Average serum half life: 1.5

Biliary penetration: Moderate

CSF penetration: Therapeutic

Lung penetration: Therapeutic

Urine penetration: Therapeutic